Answers are grounded in this paper and cite their sources.
Diagnosis of iron-induced hypophosphatemia requires clinical suspicion. Treatment is guided by the severity of hypophosphatemia, and most patients will require oral or intravenous phosphate substitution. Future treatment options could involve therapeutic anti-FGF23 antibody (KRN23). Prevention and correction of vitamin D deficiency represents a supportive treatment option.
No takes yet. Share an insight, caveat, or question.
Zoller et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: